Finding and organizing critical pharmaceutical and medtech data has long been a tedious task requiring hours spent gathering information from disparate sources.
Pharma360 aims to change that.
When product developers at Informa Pharma Intelligence sat down with customers to understand their needs, desires, and pain points through the years, a recurring theme emerged. Customers said they were spending too much time and visiting too many different websites to gather the critical information they needed to move forward. Their typical daily workflow necessitated logging in to various sites from across the Informa Pharma Intelligence portfolio. Users needed to access the vital data within the sites, but navigating across them was time consuming and often confusing. The need was there for a streamlined solution that would simplify the workflow of Pharma Intelligence customers. Driven by Pharma Intelligence’s “outside-in” commitment to delivering a solution of true value to its customers, the product development team delivered.
The result is Pharma360, a single sign-on and search solution that connects customers to the essential data they seek to inform and drive their critical business decisions. With it, customers can now easily access all of their Pharma Intelligence subscriptions with one login and password, eliminating the time-consuming hassle of accessing each site separately. This single sign-on functionality allows immediate access to Pharma Intelligence subscriptions, enabling users to access Trialtrove for updated trial activity, Pharmaprojects for new data on pipeline drugs, Datamonitor Healthcare for market forecasting and epidemiology reports, and Biomedtracker for information on new events, catalysts, and deals, as well as gleaning news and insight from visiting In Vivo, Pink Sheet, Scrip, and Medtech Insight.
But the development team didn’t stop there at creating a useful solution. Customers also expressed a need for universal searching across subscriptions, saying “We don’t want a one-stop shop; that gets messy. But giving us a high-level executive summary to help us navigate through the portfolio would be immensely useful.”
To achieve this cross-database search capability, developers aligned and mapped data across multiple independent data sets from all products in the Pharma Intelligence suite – a feat requiring the implementation of three ontologies across eight datasets – to create a standardized definition for “Disease”, “Company”, and “Drug” across the entire portfolio. Pharma360 is among the first products to use the Pharma Intelligence Data Fabric architecture, which allows for the rapid searching and surfacing of data across multiple databases.
As a result, Pharma360 enables users to instantly search for and find key summaries on drugs, diseases, and companies – plus delivers the ability to drill down into that data for specific information. Additionally, users can create their own view of the data they retrieve, constructing dashboards with relevant, essential information that answers their specific questions. To store what they find in their searches, project folders within Pharma360 afford users the ability to save relevant visuals and data points that they can return to in the future.
For example, a user seeking to answer the question, “What companies have pipeline drugs for hypoglycemia and where are they in development?” could create a dashboard that immediately pulls data from across the Pharma Intelligence suite showing the trial activity for all companies within hypoglycemia. The user could then add relevant trial and drug phase transition information, plus related reports and articles, forming a full view of the drug landscape for that disease, and save their findings in a project folder for future reference.
How effective in increasing efficiencies is the new Pharma360?
To find out, the Pharma Intelligence product team undertook a benchmarking exercise to determine improvement in speed to insight, comparing the use of Pharma360 with the traditional practice of searching across the Pharma Intelligence suite by separate product, including utilizing separate logins for each.
What they found was that by using the single sign on and search capacity of Pharma360, users enjoyed an average time savings of between 60-80%, as compared to entering separate sites and conducting separate searches among their Pharma Intelligence subscriptions. For instance, part of the benchmarking exercise involved one scenario where users needed to uncover the competitive landscape for moderate-severe Crohn’s disease, focusing on which drugs could be coming to the Japanese market in the future. Using the conventional method of research – logging into separate sites to glean the desired information – a group of minimally-biased volunteers spent 70 minutes locating the data. Using Pharma360, the search took a total of 2 minutes to uncover similar data.
Significantly increasing time to insight is a proven probability with Pharma360.
Single sign-on and a simple search from the clean, user-friendly central search page are increasing efficiencies among those tasked with gathering and organizing data on drugs, companies, and diseases from across the Pharma Intelligence portfolio. Users are finding a streamlined solution in Pharma360, enabling them to fully realize the total value of their Pharma Intelligence subscriptions.